London McDougal

London's roots lie in Portland, Oregon, but spent his formative years in Tucson, Arizona. He attended the University of Arizona and earned a BS in Plant Sciences and Biochemistry. After graduating, he worked at Roche in cancer diagnostics for almost three years before deciding to return to academia to pursue his Ph.D. Here he joined the Simpson lab to complete his doctoral studies focusing on the effects of exercise on the immune system.

Research Interest:

London's area of interest lies in enhancing the efficacy of donor lymphocyte infusions (DLI) in treating hematologic cancers, such as acute lymphoblastic leukemia (ALL), through the integration of exercise, cytokines, and CAR-T therapies. His current project involves investigating whether exercise can improve graft versus leukemia (GvL) while decreasing the frequency and severity of graft versus host disease (GvHD). In future projects, he will investigate the combination potential of exercise and cytokine stimulation in DLI therapy to further advance patient outcomes.